Clinical

Dataset Information

0

Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine


ABSTRACT: This study is being conducted to determine the efficacy, side effects, and toxicity of an investigational vaccine that consists of tumor-pulsed dendritic cells administered with an immune stimulating drug called interleukin-2 (IL-2). Dendritic cells are immune cells that are obtained from a subject’s blood and are important in the body’s immune response to foreign substances. This study will examine the response of a subject’s immune system after receiving several vaccinations containing their own dendritic cells which have been exposed to dead fragments of their cancer cells in the laboratory. This may result in sensitizing a subject’s dendritic cells to their cancer cells so that their dendritic cells will react with other cells of the immune system and attack the cancer. It has been shown in the laboratory that dendritic cells exposed to cancer cell fragments can provide lymphocytes (a type of white blood cell) with signals they require in order to become fully activated and acquire the ability to kill cancer cells.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2017769 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2621365 | ecrin-mdr-crc
| 2194539 | ecrin-mdr-crc
2011-01-20 | E-GEOD-26719 | biostudies-arrayexpress
2011-01-21 | E-GEOD-26747 | biostudies-arrayexpress
2019-11-27 | MODEL1911270001 | BioModels
2011-01-20 | GSE26719 | GEO
| PRJNA898772 | ENA
2011-01-21 | GSE26747 | GEO
2024-09-02 | BIOMD0000000880 | BioModels
2024-09-02 | BIOMD0000000888 | BioModels